Company Profile

Caeli Vascular LLC
Profile last edited on: 4/23/2021      CAGE: 88YL3      UEI: URVKGZVFL8X5

Business Identifier: Transformative new catheters for vascular surgery
Year Founded
2018
First Award
2020
Latest Award
2022
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

BioGenerator 4340 Duncan Avenue
T. Louis, MO 63110
   (314) 422-9456
   info@caelivascular.com
   www.caelivascular.com
Location: Single
Congr. District: 01
County: St. Louis

Public Profile

CaeliVascular is a medical device developer and manufacturer organized around creating solutions for venous clots. Based in St. Louis, MO and having strong ties to Washington University in that state, CaeliVascular has developed the Hydra Catheter to treat Venous Thrombosis and Pulmonary Embolism. Tackling the transforming of treatment for deep vein thrombosis and pulmonary embolism, Caeli Vascular is developing and commercializing breakthrough minimally invasive therapies for the treatment of venous thromboembolism (VTE).

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2022 2 NIH $2,144,669
Project Title: Multi-Modal Venus Clot Removal Device

Key People / Management

  Guy Genin -- Founder

  John Hardin -- Chief Executive Officer

  Maria Z Kounnas

  Mohamed A Zayed -- Assistant Professor of Surgery, Molecular Cell Biology and Biomedical Engineerin

Company News

There are no news available.